For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Search Posts
News Release
Think Tanks Urge Supreme Court to Reject Abstract Process Patents
Washington, D.C., September 15, 2011 – The Competitive Enterprise Institute, Cato Institute, and Reason Foundation have submitted an amicus curiae brief…
Citation
Colorado Cantaloupes Prompt Warning After Multi-State Listeria Outbreak
Op-Eds
How to Transcend Post-9/11 Homeland Insecurity
Is “Elevated” worse than “High,” or is it the other way around? Hell, I can’t remember. Need the iPhone app for that I guess.
Reason
Mandating Condoms?
Reason
Wanted: Alcoholic Truck Drivers
Reason